Skip to main content

Table 3 Age of death in years in patients who did not receive riboflavin treatment

From: The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives

Age of death (years) N deceased % deceased Mean age Median age Age range SD
Group 1* (N=13) 11 85% 1.9 1.9 0.9 – 3 0.6
Group 2* (N=17) 9 53% 18.5 11 7.3 – 42 11.0
Group 3* (N=27) 5 19% 18.5 17.3 12 – 25 4.6
All patients (N=61) 28 46% 11.6 9.3 0.9 – 42 11.1
  1. *Group 1: age <4 years, Group 2: age 4–10 years, Group 3: age 11–17 years.